Wojewodzki Szpital Specjalistyczny we Wroclawiu

Wroclaw 52-224

1 studies enrolling now · 14 studies all time

What they study most

Acute Coronary Syndrome, Acute Myocardial Infarction (AMI), Arthritis, Rheumatoid, Atopic Dermatitis, Cardiovascular Risk, Congenital Heart Disease, Congenital Heart Disease With Fontan Circulation, Hypertension, Pulmonary, Pulmonary Arterial Hypertension, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension — Running, not enrolling
• Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects — Completed
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus — Completed
• Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients. — Stopped early
• Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2) — Completed
• Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1) — Completed
• Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis — Completed
• Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe — Completed
• Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis — Stopped early
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis — Completed